These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24081825)

  • 21. Statins reduce dengue virus production via decreased virion assembly.
    Martínez-Gutierrez M; Castellanos JE; Gallego-Gómez JC
    Intervirology; 2011; 54(4):202-16. PubMed ID: 21293097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system.
    Dutta K; Ghosh D; Basu A
    J Neuroimmune Pharmacol; 2009 Sep; 4(3):328-37. PubMed ID: 19434500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting a host process as an antiviral approach against dengue virus.
    Sayce AC; Miller JL; Zitzmann N
    Trends Microbiol; 2010 Jul; 18(7):323-30. PubMed ID: 20452219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput screening using dengue virus reporter genomes.
    Fischl W; Bartenschlager R
    Methods Mol Biol; 2013; 1030():205-19. PubMed ID: 23821271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for the treatment of dengue virus infections: a narrative account.
    De Clercq E
    Future Med Chem; 2010 Apr; 2(4):601-8. PubMed ID: 21426010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dengue virus (DV) replication in monocyte-derived macrophages is not affected by tumor necrosis factor alpha (TNF-alpha), and DV infection induces altered responsiveness to TNF-alpha stimulation.
    Wati S; Li P; Burrell CJ; Carr JM
    J Virol; 2007 Sep; 81(18):10161-71. PubMed ID: 17626094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A small molecule fusion inhibitor of dengue virus.
    Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of dengue virus replication in cultured Aedes albopictus (C6/36) mosquito cells by the antifungal imidazoles ketoconazole and miconazole.
    Lee E; McLean K; Weir RC; Dalgarno L
    Virology; 2000 Mar; 269(1):1-6. PubMed ID: 10725192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.
    Diamond MS; Harris E
    Virology; 2001 Oct; 289(2):297-311. PubMed ID: 11689052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of intracellular events in the pathogenesis of dengue; an overview.
    Jain B; Chaturvedi UC; Jain A
    Microb Pathog; 2014; 69-70():45-52. PubMed ID: 24685697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Influence of Surface Charge on the Antiviral Effect of Curcumin Loaded in Nanocarrier System.
    Nabila N; Hassan SR; Larasati GP; Yohan B; Sasmono RT; Adi AC; Iskandar F; Rachmawati H
    Pharm Nanotechnol; 2021; 9(3):210-216. PubMed ID: 33563189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro anti-viral screening and cytotoxicity evaluation of copper-curcumin complex.
    Chauhan G; Rath G; Goyal AK
    Artif Cells Nanomed Biotechnol; 2013 Aug; 41(4):276-81. PubMed ID: 23305481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin as a natural potential drug candidate against important zoonotic viruses and prions: A narrative review.
    Azarkar S; Abedi M; Lavasani ASO; Ammameh AH; Goharipanah F; Baloochi K; Bakhshi H; Jafari A
    Phytother Res; 2024 Jun; 38(6):3080-3121. PubMed ID: 38613154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising Potential of Curcumin and Related Compounds for Antiviral Drug Discovery.
    Sharma A; Sharma T; Bhaskar R; Ola M; Sharma A; Sharma PC
    Med Chem; 2024; 20(6):597-612. PubMed ID: 38571348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Curcumin and Pentagamavunon-0 Against Dengue-2 Virus Infection in Vero Cells; an in Vitro Study.
    Marbawati D; Umniyati SR
    Procedia Environ Sci; 2015; 23():215-221. PubMed ID: 32288928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidating the Effects of Curcumin against Influenza Using In Silico and In Vitro Approaches.
    Kim M; Choi H; Kim S; Kang LW; Kim YB
    Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-infective Properties of the Golden Spice Curcumin.
    Praditya D; Kirchhoff L; Brüning J; Rachmawati H; Steinmann J; Steinmann E
    Front Microbiol; 2019; 10():912. PubMed ID: 31130924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding.
    Mounce BC; Cesaro T; Carrau L; Vallet T; Vignuzzi M
    Antiviral Res; 2017 Jun; 142():148-157. PubMed ID: 28343845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
    Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.